# Different Immunosuppressive Treatment in iMN

> **NCT04745728** · PHASE3 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 200 (estimated)

## Conditions studied

- Idiopathic Membranous Nephropathy

## Interventions

- **DRUG:** Prednisone
- **DRUG:** Cyclophosphamide
- **DRUG:** Rituximab

## Key facts

- **NCT ID:** NCT04745728
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-04-14
- **Primary completion:** 2027-12
- **Final completion:** 2029-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04745728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04745728, "Different Immunosuppressive Treatment in iMN". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04745728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*